Latest News & Updates
Breaking News
2 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Boehringer Ingelheim Gains China NMPA Conditional Approval for Zongertinib in First-Line HER2-Mutant NSCLC
Boehringer Ingelheim's zongertinib gains China NMPA conditional approval for first-line HER2-mutant NSCLC, following U.S. FDA accelerated approval in February 2026.
Pharma Now Editorial Team
Reliance Life Sciences Appoints Siva Sankar Mahamkali as VP of Biosimilars Manufacturing Operations
Reliance Life Sciences names Siva Sankar Mahamkali VP of Biosimilars Manufacturing Operations, bringing 20+ years of GMP and biologics expertise.
Pharma Now Editorial Team
Eli Lilly Appoints Chandan S. as Senior Director of Data Science and AI Engineering
Eli Lilly names Chandan S. Senior Director for Data Science and AI Engineering, embedding ML and GenAI capabilities into life sciences operations.
Pharma Now Editorial Team
Hansa Biopharma Licenses IDEFIRIX to SERB Pharmaceuticals in €115 Million European Deal
Hansa Biopharma licenses IDEFIRIX to SERB Pharmaceuticals in a €115M deal, shifting European commercial responsibility and triggering GMP compliance handoff obligations.
Pharma Now Editorial Team
